A Study of ALXN1840 (Non-coated) Administered With And Without Omeprazole In Healthy Adults

Study Identifier:
WTX101-101
ClinicalTrials.gov Identifier:
EudraCT Identifier:
N/A
Sponsor:
Alexion Pharmaceuticals, Inc.
Study Contact Information:
N/A
Study Complete

Study Details

Medical Condition
  • Other
Study Drug
  • Drug: ALXN1840
  • Drug: Omeprazole
Date
Jan 2014 - Mar 2014
Phase 1
Phase 2
Phase 3
Phase 4
N/A
Patient Requirements
Sex: Female & Male
Age: 19 - 55 Years
Requirements Information
Sex
Female & Male
Age
19 - 55 Years

Study Details

Medical Condition
  • Other
Study Drug
  • Drug: ALXN1840
  • Drug: Omeprazole
Date
Jan 2014 - Mar 2014
Phase 1
Phase 2
Phase 3
Phase 4
N/A
Patient Requirements
Sex: Female & Male
Age: 19 - 55 Years years
Requirements Information

Protocol Summary

This was single-center, open-label, randomized, 3-period, 3-treatment, 6-sequence crossover study evaluating the PK of single doses of WTX101 in healthy participants based on the measurement of plasma total Molybdenum.

Trial Locations

Location
Status
Location
Clinical Trial Site
Lincoln, Nebraska, United States, 68502
Status
N/A